London Stock Exchange welcomes Intuitive Investments Group plc to AIM

London Stock Exchange today welcomes Intuitive Investments Group plc (‘Intuitive’, the ‘Company’ or ‘Group’), an investing company focussed on gaining exposure to Life Sciences businesses, to celebrate the listing of the Company's public shares onto AIM, under the ticker "IIG".

The Company is a newly established investing company, seeking to provide investors in the Company with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board’s experience and in particular that of the Chairman, David Evans, to seek to generate capital growth over the long term for shareholders.

Strand Hanson Limited is acting as Nominated Adviser and Turner Pope Investments (TPI) Ltd is acting as Broker and Sole Bookrunner.

•    Intuitive Investments Group plc raised £7.85m gross with net proceeds being used to:
–    to invest in fast growing and / or high potential life sciences businesses, based predominantly in the UK, wider Europe and the US, chosen from an identified pipeline of investment opportunities
–    investments will be focused on diagnostics and healthcare, medical devices, tools and technologies and bio-therapeutics and pharmaceuticals

From February 2021 Rob Naylor will work alongside David and the team as Chief Executive Officer. Rob Naylor has 24 years’ experience in capital markets; most recently at Cenkos Securities plc as head of corporate finance and corporate broking in the investment funds team. Robert has advised a number of Life Science companies and has worked closely with David over many years.

David Evans, Chairman of Intuitive Investments Group plc, said: “We are really pleased to be joining AIM today. With our combined experience and demonstrative track record in the sector we look to the future and invest in fast growing and / or high potential life sciences businesses, based predominantly in the UK, wider Europe and the US, chosen from an identified pipeline of investment opportunities.

“We will look for investments focused on diagnostics and healthcare, medical devices, tools and technologies and bio-therapeutics and pharmaceuticals.”

To find out more about Intuitive Investments Group plc visit: www.iigplc.com

Quick facts

Track
Market: AIM
Instrument market cap (£m)
8.61
Listing/Admission to trading
14 Dec 2020
Looking for new and recent issues?

More recent

127.36
London Stock Exchange welcomes Ukraine’s $1.25bn international sovereign bond to the Main Market

London Stock Exchange today welcomes Ukraine issuing its USD1.25bn 6.876% notes due May 2029 to London Stock Exchange’s Main Market. This is an inaugural listing of Ukraine’s sovereign Eurobonds on London Stock Exchange.
 
The new 8-year offering, which marked the first funding exercise of the Sovereign in international debt capital markets in 2021, received bids in excess of

Learn more
122.2
London Stock Exchange welcomes Glantus Holdings PLC to AIM

London Stock Exchange today welcomes Glantus to AIM under the ticker “GLAN”, after it raised gross proceeds of £10m for the Company and a further £4m for shareholders. The Placing Price was 102 pence per share resulting in a market capitalisation of £37m at Admission.

Glantus is a global provider of Accounts Payable (“AP”) automation and analytics solutions. It utilises a technology t

Learn more
45.04
London Stock Exchange welcomes Insig AI Plc to AIM

London Stock Exchange welcomes Insig AI Plc (ticker: INSG), a leading data science and machine learning company serving the asset management industry, to AIM today.

Insig AI joins AIM via a reverse takeover of its listed holding company Catena Group plc (“Catena”).  The new enlarged group is led by Executive Chairman, Matthew Farnum-Schneider, and Chief Executive Officer Ste

Learn more
139.72
London Stock Exchange welcomes Darktrace to the Premium Segment of the Main Market

Darktrace plc, the UK-based, leading autonomous cyber security AI company, has today reached a major milestone in its trajectory of rapid growth as it is admitted to the Premium Listing Segment of the Official List. It is trading on the Main Market of London Stock Exchange, having raised gross proceeds of £165m via a global share offer.  At the placing price of 250p per share, the company

Learn more